跳至主要内容
临床试验/KCT0005305
KCT0005305尚未招募未知

Immunogenomic dynamics and biomarkers in patients with unresectable hepatocellular carcinoma receiving immunotherapy-based treatments

Asan Medical Center0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) Patients with histologically confirmed HCC,
  • 2) Patients with histologically confirmed locally advanced, recurrent or metastatic HCC, which was judged not to be eligible for surgical resection, liver transplantation or radiofrequency ablation
  • 3) Patients who will receive immuno-oncology treatment

排除标准

  • 1) Patients with histologically confirmed fibrolamellar type HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC
  • 2) Patients with concurrent other malignancy
  • 3) Patients who are candidates for local curative treatments such as hepatic resection, liver transplantation, or radiofrequency ablation
  • 4) Patients who have a possibility of confusion in the results of the clinical research

研究者

相似试验

Immunogenomic dynamics and biomarkers in patients... | 临床试验